AbbVie U-Turns On Dong-A’s MerTK Program After Development Delays

Uturn
Dong-A Yet To Determine New Development Plans after abbvie u-turn • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia